Last Updated: Aug 27, 2024
The U.S. Food and Drug Administration (FDA) approved and granted emergency use authorization (EUA) for updated mRNA COVID-19 vaccines to include a monovalent component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The U.S. Centers For Disease Control and Prevention (CDC) also approved this update and is reflected on their Interim Clinical Considerations for Use of COVID-19 Vaccines page.
Thank you for the comment! Your comment must be approved first
You've already submitted a review for this item
Thank you! Your review has been submitted successfully
Login to be able to comment
Comment cannot be empty
Rating is required
You typed the code incorrectly. Please try again